A.112 EPC Decision or opinion of the Enlarged Board of Appeal

(1)

In order to ensure uniform application of the law, or if a point of law of fundamental importance arises:

(a)

the Board of Appeal shall, during proceedings on a case and either of its own motion or following a request from a party to the appeal, refer any question to the Enlarged Board of Appeal if it considers that a decision is required for the above purposes. If the Board of Appeal rejects the request, it shall give the reasons in its final decision;

(b)

the President of the European Patent Office may refer a point of law to the Enlarged Board of Appeal where two Boards of Appeal have given different decisions on that question.

(2)

In the cases referred to in paragraph 1(a) the parties to the appeal proceedings shall be parties to the proceedings before the Enlarged Board of Appeal.

(3)

The decision of the Enlarged Board of Appeal referred to in paragraph 1(a) shall be binding on the Board of Appeal in respect of the appeal in question.

[ Art. 22 R. 111 140 ]

See decisions/opinions of the Enlarged Board of Appeal G 1/86, G 2/88, G 4/88, G 5/88, G 6/88, G 7/88, G 8/88, G 1/90, G 1/92, G 3/95, G 6/95, G 2/97, G 2/98, G 3/98, G 4/98, G 1/99, G 2/99, G 3/99, G 1/02, G 1/03, G 2/03, G 3/03, G 1/04, G 2/04, G 3/04, G 1/05, G 2/06, G 3/08, G 1/12, G 1/14, G 3/14, G 1/15, G 1/16, G 1/18, G 2/19, G 3/19 (Annex I).

Source: http://www.epo.org/law-practice/legal-texts/html/epc/2016/e/ar112.html

Date retrieved: 17 May 2021

257 references found. Limiting display to 200 references.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

X Part VI Appeals procedure

X A.22 EPC Enlarged Board of Appeal

EPC Implementing Rules

X Decision of the Administrative Council of 25 March 2015 approving amendments to the Rules of Procedure of the Enlarged Board of Appeal of the European Patent Office

X R.111 EPC Form of decisions

X R.140 EPC Correction of errors in decisions

Offical Journal of the EPO

X OJ EPO SE 2/2021, p134 - ANNEX 4

X OJ EPO SE 2/2021, p63 - V. PROCEEDINGS BEFORE THE BOARDS OF APPEAL

X OJ EPO SE 2/2021, p49 - IV. PROCEEDINGS BEFORE THE DEPARTMENTS OF FIRST INSTANCE

X OJ EPO SE 1/2021, p183 - Annex 2. Table setting out the amendments to the RPBA and the explanatory remarks

X OJ EPO SE 1/2021, p115 - XI.2 - Electronic filing of documents

X OJ EPO SE 1/2021, p41 - III.2 - Rules of Procedure of the Boards of Appeal 2020 [ 1 ]

Case Law Book

X CLR FOREWORD to the ninth edition

X CLR RPBA2020 Rules of Procedure of the Boards of Appeal – in force as from 1 January 2020

X CLR RPEBA Rules of Procedure of the Enlarged Board of Appeal

Case Law Book: I Patentability

X CLR I A 2.4.4.B Exclusion of computer programs under Article 52(2) and (3) EPC

X CLR I B 3.3.3 Product claims for plants or plant material

Case Law Book: II Conditions to be met by an Application

X CLR II E 2.4.12 Replacement of substance by device containing substance or substance with mechanical device

X CLR II F 5 Double patenting

Case Law Book: V Priority

X CLR V A 2.5.3 Appeal filed within the time limit

X CLR V A 9.3.4 Inadmissible or deemed not to be filed – diverging case law and G 1/18

X CLR V B 1 Introduction

X CLR V B 2.1 General

X CLR V B 2.2 Composition

X CLR V B 2.3.1 General

X CLR V B 2.3.2 Discretion of the board

X CLR V B 2.3.5 Pending proceedings

X CLR V B 2.3.6 Ensuring uniform application of the law

X CLR V B 2.3.7 Point of law of fundamental importance

X CLR V B 2.4.1 General

X CLR V B 2.4.2 Discretion of the President

X CLR V B 2.4.3 Differing decisions

X CLR V B 2.4.4 Two boards of appeal

X CLR V B 2.5.1 Question already decided by the Enlarged Board

X CLR V B 2.5.4 Stay of appeal proceedings following a referral

X CLR V B 3.4.3 No suspensory effect – review of substantive law excluded

Case Law of the Enlarged Board

X G 0001/86 (Re-establishment of rights of opponent) of 24.6.1987

X G 0002/88 (Friction reducing additive) of 11.12.1989

X G 0004/88 (Transfer of opposition) of 24.4.1989

X G 0005/88 (Administrative Agreement) of 16.11.1990

X G 0006/88 (Plant growth regulating agent/BAYER) of 11.12.1989

X G 0007/88 (Administrative Agreement) of 16.11.1990

X G 0008/88 (Administrative Agreement) of 16.11.1990

X G 0001/90 (Revocation of the Patent) of 5.3.1991

X G 0001/92 (Availability to the public) of 18.12.1992

X G 0003/95 (Inadmissible referral) of 27.11.1995

X G 0006/95 (Interpretation of Rule 71a(1) EPC) of 24.7.1996

X G 0002/97 (Good faith) of 12.11.1998

X G 0002/98 (Requirement for claiming priority of the "same invention") of 31.5.2001

X G 0003/98 (Six-month period/UNIVERSITY PATENTS) of 12.7.2000

X G 0004/98 (Designation fees) of 27.11.2000

X G 0001/99 (Reformatio in peius / 3M) of 2.4.2001

X G 0002/99 (Six-month period) of 12.7.2000

X G 0003/99 (Admissibility of joint opposition or joint appeal/HOWARD FLOREY) of 18.2.2002

X G 0001/02 (Formalities officers' powers) of 22.1.2003

X G 0001/03 (Disclaimer/PPG) of 8.4.2004

X G 0002/03 (Disclaimer/GENETIC SYSTEMS) of 8.4.2004

X G 0003/03 (Reimbursement of the appeal fee/HIGHLAND) of 28.1.2005

X G 0001/04 (Diagnostic methods) of 16.12.2005

X G 0002/04 (Transfer of opposition/HOFFMANN-LA ROCHE) of 25.5.2005

X G 0003/04 (Intervention/EOS) of 22.8.2005

X G 0001/05 (Exclusion and objection/XXX) of 7.12.2006

X G 0002/06 (Use of embryos/WARF) of 25.11.2008

X G 0003/08 (Programs for computers) of 12.5.2010

X G 0001/09 (Pending application/SONY) of 27.9.2010

X G 0001/10 (Request to correct patent/FISHER-ROSEMOUNT) of 23.7.2012

X G 0001/11 (Non-refund of further search fees/BAUER) of 19.3.2014

X G 0001/12 () of 30.4.2014

X G 0002/12 () of 25.3.2015

X G 0001/13 (Fischer-Tropsch Catalysts/SASOL TECHNOLOGY II) of 25.11.2014

X G 0002/13 () of 25.3.2015

X G 0001/14 (Referral to the Enlarged Board of Appeal) of 19.11.2015

X G 0003/14 () of 24.3.2015

X G 0001/15 () of 29.11.2016

X G 0001/16 (Disclaimer III) of 18.12.2017

X G 0001/18 (Filing an appeal) of 18.7.2019

X G 0002/19 (Rechtliches GehÃ¶r und richtiger Verhandlungsort) of 16.7.2019

X G 0003/19 (Pepper (follow-up to ÂTomatoes IIÂ and ÂBroccoli IIÂ)) of 14.5.2020

General Case Law

X J 0008/07 (Langue de la procÃ©dure) of 1.7.2010

X J 0001/09 (Otoplastik fÃ¼r Hinter-dem-Ohr-HÃ¶rgerÃ¤te/ERICH BAYER) of 6.10.2009

X J 0024/10 () of 15.4.2011

X J 0029/10 (RÃ¼ckzahlung der WeiterbehandlungsgebÃ¼hr wegen rechtswidriger … of 18.11.2011

X J 0001/11 (Retraction of withdrawal (not allowed)) of 28.6.2011

X J 0005/11 () of 6.6.2012

X J 0017/12 () of 13.11.2013

X J 0013/13 (Frist zur Einreichung einer Teilanmeldung) of 15.9.2016

X J 0022/13 () of 1.9.2015

X J 0013/14 () of 13.12.2016

X R 0005/08 () of 5.2.2009

X R 0016/10 () of 20.12.2010

X R 0001/11 () of 27.6.2011

X R 0008/11 () of 29.11.2011

X R 0007/12 () of 6.12.2013

X R 0005/13 (Fundamental violation of Article 113 EPC) of 10.2.2014

X R 0007/13 (Petition for review) of 26.10.2016

X R 0009/13 (Fundamental violation of Article 113 EPC) of 10.2.2014

X R 0010/13 (Fundamental violation of Article 113 EPC) of 10.2.2014

X R 0011/13 (Fundamental violation of Article 113 EPC) of 10.2.2014

X R 0012/13 (Fundamental violation of Article 113 EPC) of 10.2.2014

X R 0013/13 (Fundamental violation of Article 113 EPC) of 10.2.2014

X R 0017/13 () of 13.9.2013

X R 0002/14 (Objections to the Chairman and Members of the Enlarged Board of … of 17.2.2015

X R 0004/14 () of 6.6.2016

X R 0018/14 () of 22.5.2015

X R 0006/15 () of 25.4.2016

X R 0003/18 () of 12.11.2018

X T 0725/05 (Humanized Immunoglobulins II/PDL) of 14.10.2009

X T 1131/05 () of 19.2.2008

X T 1421/05 () of 18.1.2011

X T 1753/06 (tert-butylamine du perindopril/LABORATOIRES SERVIER) of 6.5.2009

X T 0193/07 (Arsenic-free glasses/CORNING) of 11.5.2011

X T 1423/07 (Cyclic Amine derivative/BOEHRINGER INGELHEIM VETMEDICA GmbH) of 19.4.2010

X T 1755/07 () of 4.12.2009

X T 0413/08 () of 8.12.2009

X T 0547/08 () of 10.3.2011

X T 0608/08 () of 22.7.2010

X T 0960/08 (Transfer of opposition/VDO Automotive AG) of 1.12.2011

X T 1248/08 (Coating solution/SUMITOMO METAL MINING CO. LTD) of 16.2.2012

X T 1349/08 (Hydrocarbon preparation/AGIP PETROLI) of 16.3.2010

X T 1548/08 () of 8.4.2010

X T 1650/08 (Pseudotyped HIV-based retrovirus/OXFORD BIOMEDICA) of 2.10.2012

X T 1741/08 (GUI layout/SAP) of 2.8.2012

X T 1798/08 () of 21.8.2012

X T 1926/08 () of 3.5.2011

X T 2003/08 (Dilated cardiomyopathy/EDWARDS) of 31.10.2012

X T 0365/09 () of 14.4.2010

X T 1099/09 () of 12.1.2012

X T 1782/09 () of 5.5.2011

X T 1938/09 (Objection for suspicion of partiality) of 2.10.2014

X T 1959/09 () of 20.6.2012

X T 1961/09 () of 26.6.2013

X T 2273/09 (CXCR4 inhibition for inhibiting vascularization/CHUGAI) of 19.11.2014

X T 0028/10 (Fungizide Wirkstoffkombination/BAYER CROPSCIENCE AG) of 12.12.2011

X T 0128/10 () of 10.12.2010

X T 0253/10 () of 16.3.2012

X T 0311/10 () of 8.5.2012

X T 0347/10 (Dichtmasse/Silu Verwaltung AG) of 7.11.2013

X T 0712/10 () of 25.10.2012

X T 0773/10 () of 24.10.2014

X T 1016/10 () of 11.4.2014

X T 1100/10 (Detergent Bacillus lentus subtilisin protease egg stains/BASF) of 18.3.2014

X T 1500/10 () of 20.12.2012

X T 1542/10 (Optical amplifier/FUJITSU) of 6.11.2013

X T 1836/10 (Gewinnung von embryonalen Stammzellen/WÃRFEL) of 9.4.2013

X T 2133/10 () of 1.8.2012

X T 2369/10 () of 13.11.2015

X T 0280/11 () of 1.7.2014

X T 0285/11 (EVONIK DEGUSSA / SUMITOMO CHEMICAL COMPANY) of 21.11.2014

X T 0287/11 () of 1.4.2014

X T 0985/11 (Delta-4 desaturase/ABBOTT) of 9.9.2015

X T 1467/11 () of 24.7.2012

X T 1673/11 (Treatment of Pompe's disease/GENZYME) of 20.10.2015

X T 1873/11 () of 25.2.2016

X T 2159/11 () of 13.1.2015

X T 2563/11 (Doppelpatentierung) of 5.9.2017

X T 0001/12 () of 10.2.2017

X T 0066/12 () of 9.11.2016

X T 0074/12 (Autotherme Reformierung/MG TECHNOLOGIES AG, AMMONIA CASALE S.A.) of 25.2.2014

X T 0198/12 () of 14.1.2014

X T 0373/12 (Examination of clarity of amended claims by opposition divisions and … of 2.4.2014

X T 0642/12 (Reduced appeal fee/LELY ENTERPRISES AG) of 11.1.2013

X T 0854/12 (Unterbrechung des Verfahrens) of 8.8.2016

X T 1050/12 (Treatment of stress urinary incontinence/UNIVERSITY OF PITTSBURGH) of 22.1.2018

X T 1142/12 () of 8.4.2014

X T 1162/12 () of 3.5.2017

X T 1364/12 () of 12.2.2015

X T 1461/12 (Two unlock keys/UNILOC) of 4.8.2015

X T 2101/12 (Authentication binding document with signature/VASCO) of 24.1.2018

X T 2177/12 () of 24.7.2013

X T 2357/12 (Universal succession) of 28.11.2013

X T 2440/12 (Fluid flow simulation/SIMCON) of 15.9.2015

X T 2453/12 () of 24.5.2016

X T 0160/13 () of 23.4.2015

X T 0558/13 () of 4.11.2013

X T 0560/13 () of 4.11.2013

X T 0793/13 () of 21.3.2017

X T 1226/13 () of 19.9.2018

X T 1434/13 (Container with band header/DUBOIS) of 13.9.2016

X T 1553/13 (Inadmissibility of an appeal where the appeal fee is paid after … of 20.2.2014

X T 1852/13 () of 31.1.2017

X T 2249/13 (Mobile device/TRADE CAPTURE) of 17.10.2014

X T 0107/14 () of 22.9.2015

X T 0213/14 () of 24.4.2018

X T 0489/14 (Pedestrian simulation/CONNOR) of 22.2.2019

X T 0598/14 (Enhanced retrieval/BRITISH TELECOMMUNICATIONS) of 6.11.2014

X T 0725/14 () of 21.1.2019

X T 1516/14 () of 8.6.2018

X T 1954/14 () of 13.5.2016

X T 1957/14 (Quantitative trait loci/ SYNGENTA) of 17.1.2018

X T 2068/14 (Displaying battery information/PSION) of 30.7.2015

X T 0449/15 (Antimicrobial material/CONVATEC) of 25.2.2016

X T 1477/15 () of 23.2.2017

X T 1691/15 () of 27.7.2016

X T 0084/16 (PAR-1 activation/TUFTS) of 27.1.2017

X T 0488/16 (Dasatinib/BRISTOL-MYERS SQUIB) of 1.2.2017

X T 0506/16 (Correction of patent/DOW GLOBAL) of 20.6.2018

X T 1823/16 (Network Adapter/SONY ERICSSON) of 28.6.2018

X T 2136/16 () of 11.9.2017

X T 0831/17 (Haar oder MÃ¼nchen als Ort der mÃ¼ndlichen Verhandlung) of 25.2.2019

X T 1063/18 (Extreme dark green, blocky peppers/SYNGENTA) of 5.12.2018